Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2005

01-02-2005 | Editorial

23 years editorship of Clinical Rheumatology: experiences and perspectives

Author: Jan Dequeker

Published in: Clinical Rheumatology | Issue 1/2005

Login to get access

Excerpt

After 23 years, readers have probably forgotten that Clinical Rheumatology was born in Belgium. Whether one likes it or not, at present the scientific Esperanto is English. Therefore, the Royal Belgian Rheumatology Society decided in 1981 to change its 35-year-old journal Acta Rheumatologica Belgica into an international peer-reviewed journal [1]. A number of my friends, distinguished rheumatologists from Europe and other continents, agreed to join the editorial board. …
Literature
Dequeker J (1982) Why a new international rheumatology journal? Clin Rheumatol 1:9CrossRef
Dequeker J (1983) Clinical Rheumatology and the medical information balloon. Clin Rheumatol 2:11–12CrossRef
Dequeker J (1993) Clinical Rheumatology in its tenth year. Clin Rheumatol 1:1
Dequeker J (1998) Clinical Rheumatology: challenging the future with a new cover and publisher. Clin Rheumatol 17:1–2
Dequeker J (2002) Clinical Rheumatology: past-present-future. Clin Rheumatol 21:1–2CrossRef
Dequeker J, Rasker JJ (2000) Rheumatology and the Bone and Joint Decade 2000–2010, ILAR-UMER 2000 Project. Clin Rheumatol 19:79–81PubMedCrossRef
Dequeker J, Rasker JJ, El-Hadidi T (2001) Globalisation of rheumatology: activities of ILAR. Think global—act local. J Rheumatol 28:227–231PubMed
Metadata
Title
23 years editorship of Clinical Rheumatology: experiences and perspectives
Author
Jan Dequeker
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-1057-6

Other articles of this Issue 1/2005

Clinical Rheumatology 1/2005 Go to the issue

Original Article

Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms

Case Report

Transverse myelitis in a patient with Behcet’s disease: favorable outcome with a combination of interferon-α

Case Report

Chyle and gout causing acute monoarthritis: some unusual findings

Case Report

Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide

Original Article

Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)

Original Article

Levels of soluble E-selectin in patients with active Behçet’s disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits